Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions, will begin construction of a new U.S. facility in Fishers, IN, this month. The site is expected to be operational in 2023 and provides closer proximity to Stevanato Group’s North America pharmaceutical customers and an additional supply source for its products to serve customers better.
 
Stevanato Group plans to invest approximatively $145 million to build and equip the manufacturing facility. The 370,000 sq.-ft. plant will support the expansion and production of the company’s EZ-Fill solutions, pre-sterilized drug containment systems for pharmaceutical use. The facility is expected to house state-of-the-art production lines equipped with advanced process technologies to produce EZ-Fill syringes and vials. Stevanato Group’s EZ-Fill solutions are designed to reduce time to market, lower overall total cost of ownership and reduce supply chain risk.
 
The new facility will also house a center for after-sales support dedicated to serving its North America engineering customers, offering technical support as well as maintenance for visual inspection, assembly and packaging equipment.
 
“We are thrilled to begin construction on our new U.S. hub, and expand our presence in one of the fastest growing markets where we see increasing demand. We believe this will allow us to further enhance our services to our valued North America customers and underscores our desire to ensure supply chain security, just in time delivery and reliable sourcing in terms of surge capacity,” said Franco Moro, Stevanato Group Chief Executive Officer.
 
Stevanato Group’s facility is expected to be part of a new pharmaceutical and life sciences park in Fishers, and the company intends to hire more than 230 new local employees by the end of 2025 for roles in production, engineering and maintenance, as well as other corporate support positions.